TSAAI 2019 Annual Meeting
This activity will provide physicians and other conference attendees knowledge about new developments and updates in the field of allergy, asthma and immunology. Learners will gain expertise in how to facilitate adherence, and how to choose from among the therapies in the recently expanded armamentarium. In addition to a review of relevant guidelines and recent clinical studies, lectures will include the use of illustrative patient vignettes challenging learners to formulate and justify diagnostic and treatment strategies for patients. Areas of discussion will include asthma, PIDD and chronic rhinosinusitis.
This activity is supported by a medical education grant from CSL Behring.
Practicing allergists and allied healthcare providers in the field of allergy, asthma and immunology.
At the conclusion of this activity, participants should be able to:
- Screen for common non-infectious complications of common variable immune deficiency.
- Recognize how to treat asthma, chronic sinusitis, and eosinophilic esophagitis with biologics and how to obtain reimbursement for treatment.
- Describe how to manage a patient who has sensitivity to alpha-gal.
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 7 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 7.00 AMA PRA Category 1 Credit™
- 7.00 Attendance